Kinnevik AB (publ)
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed October 15, 2024), Kinnevik AB (publ) reported 1 stock position worth $78.5 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 100.0% of the portfolio. Its holdings were unchanged from Q2 2024.
- Most Recent 13F
- Q3 2025
- Location
- STOCKHOLM, V7
- CIK
- 0001766574
- Portfolio Value
- $78.5M (Q3 2024)
- SEC Filing
- 0001104659-24-108590 ↗ filed Oct 15, 2024
Holdings Value
Holdings 1 stocks · $78.5M
| RXRX Recursion Pharmaceuticals-A | 100.00% | 11,905,668 | $78.5M | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||